A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults

• Автори: Geert Leroux-Roels (Автор), Maria Lattanzi (Автор), Claudia Dovali Solis (Автор), Mario Contorni (Автор), Marco Costantini (Автор), Luca Moraschini (Автор), Monia Bardelli (Автор), Sylvie Bertholet (Автор), Erica Borgogni (Автор), Francesca Buricchi (Автор), Rocco Cantisani (Автор), Elisa Faenzi (Автор), Oretta Finco (Автор), Rosanna Leuzzi (Автор), Mariagrazia Pizza (Автор), Domenico Rosa (Автор), Francesca Schiavetti (Автор), Anja Seubert (Автор), Fabiana Spensieri (Автор), Gianfranco Volpini (Автор), Luisanna Zedda (Автор), Giuseppe Del Giudice (Автор), Ilaria Galgani (Автор)
• Формат: Книга
• Опубліковано: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries. This randomized, controlled, observer-blind phase I study and extension study in Belgium (March 2012-June 2015) assessed safety and immunogenicity of investigational acellular pertussis vaccines containing genet...